{"id":8213,"date":"2015-12-10T12:31:30","date_gmt":"2015-12-10T11:31:30","guid":{"rendered":"http:\/\/k2info.w.uib.no\/?p=8213"},"modified":"2015-12-10T12:31:30","modified_gmt":"2015-12-10T11:31:30","slug":"seminar-lets-talk-about-drugs-from-basic-science-to-clinical-trials","status":"publish","type":"post","link":"https:\/\/k2info.w.uib.no\/en\/2015\/12\/10\/seminar-lets-talk-about-drugs-from-basic-science-to-clinical-trials\/","title":{"rendered":"Seminar: \u201cLet\u00b4s talk about drugs \u2013 from basic science to clinical trials\u201d"},"content":{"rendered":"<p>[:no]<strong>The seminar will take place on the 17<sup>th<\/sup> of December 2015, 3<sup>rd<\/sup> floor conference\u00a0room, BBB, 12:00-15:00.<br \/>\n<\/strong>Please save the date!<br \/>\nThe seminar is open to everyone interested; hope to see you there!\u00a0<!--more--><\/p>\n<p>The committee is proud to present \u201c<em>Let\u00b4s talk about drugs \u2013 from basic science to clinical trials\u201d <\/em>as the next seminar in the THC-seminar series.<\/p>\n<p>Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) are two of the main research focuses for the hematological research groups at the Department of Clinical Science, UiB. In this seminar, we will highlight the progress that has been made, both in basic science, as well as in novel clinical trials performed in Bergen. Through our close collaboration with clinicians and patients, it has been possible for us to perform<em> in vitro <\/em>experiments using primary patient cells, and has also allowed the scientists to develop personalized mouse avatars derived from patient`s leukemic cells. During the presentations at this seminar, you will learn more about these exciting experiments, including insights into emerging drugs for the treatment of MDS and new clinical trials recruiting and treating patients with hematological malignancies in Bergen.<\/p>\n<p><a href=\"http:\/\/k2info.w.uib.no\/files\/2015\/12\/Plakat-Program-Desember-2015.pdf\" target=\"_blank\">Link to the programme<\/a>.[:en]<strong>The seminar will take place on the 17<sup>th<\/sup> of December 2015, 3<sup>rd<\/sup> floor conference\u00a0room, BBB, 12:00-15:00.<br \/>\n<\/strong>Please save the date!<br \/>\nThe seminar is open to everyone interested; hope to see you there!\u00a0<!--more--><\/p>\n<p>The committee is proud to present \u201c<em>Let\u00b4s talk about drugs \u2013 from basic science to clinical trials\u201d <\/em>as the next seminar in the THC-seminar series.<\/p>\n<p>Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) are two of the main research focuses for the hematological research groups at the Department of Clinical Science, UiB. In this seminar, we will highlight the progress that has been made, both in basic science, as well as in novel clinical trials performed in Bergen. Through our close collaboration with clinicians and patients, it has been possible for us to perform<em> in vitro <\/em>experiments using primary patient cells, and has also allowed the scientists to develop personalized mouse avatars derived from patient`s leukemic cells. During the presentations at this seminar, you will learn more about these exciting experiments, including insights into emerging drugs for the treatment of MDS and new clinical trials recruiting and treating patients with hematological malignancies in Bergen.<\/p>\n<p><a href=\"http:\/\/k2info.w.uib.no\/files\/2015\/12\/Plakat-Program-Desember-2015.pdf\" target=\"_blank\">Link to the programme<\/a>.<\/p>\n<p>&nbsp;[:]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[:no]The seminar will take place on the 17th of December 2015, 3rd floor conference\u00a0room, BBB, 12:00-15:00. Please save the date! The seminar is open to everyone interested; hope to see you there!\u00a0<\/p>\n<p class=\"more-link-p\"><a class=\"more-link\" href=\"https:\/\/k2info.w.uib.no\/en\/2015\/12\/10\/seminar-lets-talk-about-drugs-from-basic-science-to-clinical-trials\/\">Read more &rarr;<\/a><\/p>\n","protected":false},"author":3238,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[44],"tags":[64970],"class_list":["post-8213","post","type-post","status-publish","format-standard","hentry","category-nyheter","tag-64970"],"_links":{"self":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/8213","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/users\/3238"}],"replies":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/comments?post=8213"}],"version-history":[{"count":1,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/8213\/revisions"}],"predecessor-version":[{"id":8215,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/8213\/revisions\/8215"}],"wp:attachment":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/media?parent=8213"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/categories?post=8213"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/tags?post=8213"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}